Article
Adeno-Associated Virus Gene Therapy for Liver Disease
29 Nov 2016
Abstract excerpt
The field of adeno-associated virus (AAV) gene therapy has progressed rapidly over the past decade, with the advent of novel capsid serotype and organ-specific promoters, and an increasing understanding of the immune response to AAV administration. In particular, liver-directed therapy has made remarkable strides, with a number of clinical trials currently planned and ongoing in hemophilia A and B, as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
